Details for New Drug Application (NDA): 214271
✉ Email this page to a colleague
The generic ingredient in IODIXANOL is iodixanol. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the iodixanol profile page.
Summary for 214271
Tradename: | IODIXANOL |
Applicant: | Hengrui Pharma |
Ingredient: | iodixanol |
Patents: | 0 |
Pharmacology for NDA: 214271
Mechanism of Action | X-Ray Contrast Activity |
Suppliers and Packaging for NDA: 214271
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
IODIXANOL | iodixanol | INJECTABLE;INJECTION | 214271 | ANDA | FRESENIUS KABI USA, LLC | 65219-381 | 65219-381-10 | 10 BOTTLE, PLASTIC in 1 BOX (65219-381-10) / 100 mL in 1 BOTTLE, PLASTIC (65219-381-03) |
IODIXANOL | iodixanol | INJECTABLE;INJECTION | 214271 | ANDA | FRESENIUS KABI USA, LLC | 65219-381 | 65219-381-50 | 10 BOTTLE, PLASTIC in 1 BOX (65219-381-50) / 150 mL in 1 BOTTLE, PLASTIC (65219-381-05) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 55% | ||||
Approval Date: | May 19, 2022 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 65.2% | ||||
Approval Date: | May 19, 2022 | TE: | AP | RLD: | No |
Complete Access Available with Subscription